Medical News

RSS

University Medical Center's first atrial fibrillation unit opens in Germany

Nearly 1.8 million people in Germany suffer from atrial fibrillation. This is the most common and clinically significant form of heart rhythm disorder. Shortness of breath, a sudden sense of dizziness, a feeling of pressure in the chest, and palpitations or thumping of the heart so extreme it can be felt beating rapidly and irregularly - this is how many patients describe their first episode of atrial fibrillation.

30 Oct 2014

UT Southwestern Medical Center unveils new $800 million hospital

UT Southwestern Medical Center will unveil its new $800 million hospital at a dedication ceremony today. The 12-floor, 460-bed facility is being hailed as a patient-centered, state-of-the-art medical innovation for the people of Dallas, North Texas, and beyond.

30 Oct 2014

Study on papillary thyroid carcinoma to be presented at 84th Annual Meeting of the ATA

The prevalence of papillary thyroid carcinoma (PTC), the most common type of thyroid cancer, is increasing rapidly. New research to determine the impact of radioactive iodine (RAI) therapy on survival in PTC, describing a novel blood test able to detect circulating BRAFV600E-positive tumor DNA, and identifying a long non-coding RNA specifically associated with the thyroid that is down-regulated in PTC compared to normal thyroid tissue in patient-derived clinical specimens and cell cultures will be featured in oral presentations delivered at the 84th Annual Meeting of the American Thyroid Association, October 29-November 2, 2014, in Coronado, California.

30 Oct 2014

New Frost & Sullivan report analyzes EHR usability

Electronic health records uptake in the U.S. has accelerated dramatically as a result of government initiatives and the considerable resources – both capital and time - healthcare providers have invested over the past five years. Electronic health records have become the heart of health IT, and U.S. clinicians use them on a daily basis.

30 Oct 2014

MiMedx Group revenue up 108% in third quarter 2014

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its results for the third quarter ended September 30, 2014.

30 Oct 2014

KU researchers find potential therapeutic target for triple-negative breast cancer

A team at the University of Kansas School of Medicine has identified a potential target for treating breast cancer, including a particularly deadly form of the disease.

30 Oct 2014

Neurocrine Biosciences' NBI-98854 drug gets breakthrough designation for tardive dyskinesia

Neurocrine Biosciences, Inc. announced today that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for its Vesicular Monoamine Transporter 2 inhibitor, NBI-98854, in tardive dyskinesia.

30 Oct 2014

BloodCenter of Wisconsin announces availability of cancer mutation HemeOnc Panel

BloodCenter of Wisconsin's Diagnostic Laboratories today announced the availability of a comprehensive cancer mutation HemeOnc Panel using next generation sequencing (NGS) technology. The NGS panel developed by BloodCenter of Wisconsin is designed to detect variants in 30 genes that are either prognostic or diagnostic for 10 different myeloid hematologic malignancies.

30 Oct 2014

GNC Holdings' consolidated revenue decreases 2.7% to $656.3 million in Q3 2014

GNC Holdings, Inc., a leading global specialty retailer of health and wellness products, today reported its financial results for the quarter and year-to-date periods ended September 30, 2014.

30 Oct 2014

Novel therapeutic approaches to improve thyroid cancer outcomes

Novel therapeutic approaches to improve outcomes in thyroid cancer, for example using targeted delivery of cytotoxic drugs to tumor cells, will be among the topics featured in oral and poster presentations delivered at the 84th Annual Meeting of the American Thyroid Association, October 29-November 2, 2014, in Coronado, California.

30 Oct 2014

New research findings on Graves' disease to be highlighted at ATA meeting

A unique mouse model of Graves' disease, an autoimmune disorder that causes hyperthyroidism, and new research findings that may help improve the treatment of Graves' disease will be highlighted in oral and poster presentations at the 84th Annual Meeting of the American Thyroid Association, October 29-November 2, 2014, in Coronado, California.

30 Oct 2014

Four ACS members named recipients of ACS/Pfizer Surgical Humanitarian and Volunteerism Awards

Earlier this evening, four members of the American College of Surgeons were named recipients of the 2014 ACS/Pfizer Surgical Humanitarian and Volunteerism Awards in recognition of their selfless efforts as volunteer surgeons who provide care to medically underserved patients, domestically and abroad.

30 Oct 2014

Illicit drug use, tourism contribute to elevated HIV/AIDS risk in the Dominican Republic

The Caribbean has the second highest global human immunodeficiency virus (HIV) prevalence in the world outside of Sub-Saharan Africa, with HIV/AIDS as leading cause of death among people aged 20–59 years within the region. Particularly hard-hit are the Dominican Republic (DR) and Haiti, on the island of Hispaniola, accounting for approximately 70% of all people living with HIV in the Caribbean region.

30 Oct 2014

WUSM researchers sequence genome of enterovirus D68 samples from patients

Researchers at Washington University School of Medicine in St. Louis have sequenced the genome of enterovirus D68 sampled from patients treated at St. Louis Children's Hospital. Nationwide, the virus has spread rapidly in recent months and caused severe respiratory illness in young children, with some patients requiring hospitalization.

30 Oct 2014

New blood test could predict early onset Alzheimer’s disease with high accuracy

The research team previously identified that changes in the brain occur two decades before patients show signs of dementia. These changes can be detected through expensive brain imaging procedures.

30 Oct 2014

Auxilium Pharmaceuticals reports total revenues of $109.6 million for Q3 2014

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced financial results for the third quarter ending September 30, 2014.

30 Oct 2014

International Aspirin Foundation introduces two biennial awards

In celebration of the 40th anniversary of the formation of The International Aspirin Foundation, we are delighted to announce the introduction of two biennial awards; a Senior Science Award and a Young Investigator Award.

30 Oct 2014

Researchers examine accuracy of GenoType MTBDRslassay for detection of drug-resistant TB

Researchers from the Cochrane Infectious Diseases Group, hosted at LSTM, have conducted an independent review to examine the diagnostic accuracy of the GenoType MTBDRslassay for the detection of resistance to second-line anti-tuberculosis drugs.

30 Oct 2014

NCI supports further clinical development of next-generation HPV vaccine

The National Cancer Institute in the USA is supporting the new vaccine developed at the MedUni Vienna against the human papillomavirus (HPV) with at least US$ 3.5 million. This is a major success for the developers and means that the foundations can now be laid for the clinical trials needed for licensing as a vaccine.

30 Oct 2014

Researchers describe new progress in treatment of brain cancer, other neurological diseases

A new technology that may assist in the treatment of brain cancer and other neurological diseases is the subject of an article in a recent issue of the journal Technology, published by World Scientific Publishing Company.

30 Oct 2014

Medical News

University Medical Center's first atrial fibrillation unit opens in Germany

UT Southwestern Medical Center unveils new $800 million hospital

Study on papillary thyroid carcinoma to be presented at 84th Annual Meeting of the ATA

New Frost & Sullivan report analyzes EHR usability

MiMedx Group revenue up 108% in third quarter 2014

KU researchers find potential therapeutic target for triple-negative breast cancer

Neurocrine Biosciences' NBI-98854 drug gets breakthrough designation for tardive dyskinesia

BloodCenter of Wisconsin announces availability of cancer mutation HemeOnc Panel

GNC Holdings' consolidated revenue decreases 2.7% to $656.3 million in Q3 2014

Novel therapeutic approaches to improve thyroid cancer outcomes

New research findings on Graves' disease to be highlighted at ATA meeting

Four ACS members named recipients of ACS/Pfizer Surgical Humanitarian and Volunteerism Awards

Illicit drug use, tourism contribute to elevated HIV/AIDS risk in the Dominican Republic

WUSM researchers sequence genome of enterovirus D68 samples from patients

New blood test could predict early onset Alzheimer’s disease with high accuracy

Auxilium Pharmaceuticals reports total revenues of $109.6 million for Q3 2014

International Aspirin Foundation introduces two biennial awards

Researchers examine accuracy of GenoType MTBDRslassay for detection of drug-resistant TB

NCI supports further clinical development of next-generation HPV vaccine

Researchers describe new progress in treatment of brain cancer, other neurological diseases

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Membrane proteins in focus: Turning high-risk targets into routine workflows

Latest News